Valeant Pharmaceuticals Intl Inc (VRX) Stock Enters ‘Survivor Mode’

Valeant Pharmaceuticals (VRX) has to sell the family silver to pay debts, and its business model is under attack. VRX stock might not make it. More 

3 Stocks to Watch on Tuesday: Hertz Global Holdings, Inc (HTZ), Priceline Group Inc (PCLN) and Mylan NV (MYL)

Hertz (HTZ) is cratering on earnings, Priceline (PCLN) earned a boost off its report and Mylan (MYL) is back in headlines over EpiPen issues. More 

3 Pharma Stocks That Could Be Gutted If Marijuana Wins

If marijuana initiatives perform well on Election Day, opioid pharma stocks such as MYL, DEPO and INSY could be the big losers. More 

3 Big Pharma Stocks Under Pressure From Washington

We cover the technical condition of three Big Pharma stocks, with the help of Profit Scanner, to determine where their prices may be headed. More 

5 Healthcare Stocks Poised to Trump Q3 Earnings

Medical is one of the sectors that is witnessing earnings and revenue growth this quarter, and these 5 healthcare stocks are set to beat More 

Valeant Pharmaceuticals Intl Inc (VRX) Is What’s Wrong With America

Valeant Pharmaceuticals have made bad choices that have punished VRX stock holders. But those investors are hardly alone anymore. More 

Mylan NV (MYL) Stock Holders Can Shrug Off Kaleo’s EpiPen Threat

MYL isn't in trouble after Kaleo's announcement because Mylan stock has already accounted for the damage done by lower EpiPen sales. More